Evaluation of a neurokinin-1 antagonist in preventing multiple-day cisplatin-induced nausea and vomiting

Evaluation of a neurokinin-1 antagonist in preventing multiple-day cisplatin-induced nausea and vomiting

To perform a prospective non-randomized comparison of the effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment with the standard multiple-day cisplatin regimen for the prevention of cisplatin-induced nausea and vomiting (CINV).

Bibliographic Details
Main Authors: Li Quanfu, Wang Wenjuan, Chen Gang, Deng Shuqin, Jiang Caihong, Chen Feng, Zhao Jun, Li Hui, Bai Xiaojun, Hu Yuliang, Da Lenggaowa, Wu Yungaowa, Jin Gaowa
Format: Article
Language:English
Published: De Gruyter 2018-03-01
Series:Open Medicine
Subjects:
aprepitant
cinv
multiple-day cisplatin chemotherapy
Online Access:https://doi.org/10.1515/med-2018-0005

Internet

https://doi.org/10.1515/med-2018-0005

Similar Items